9 Results for "

10-HETE

" in MedChemExpress (MCE) Product Catalog:
Products (9)

9 Results for "10-HETE" in MCE Product Catalog:

2
2 Cited Publications
Cat. No.: HY-113439
CAS No.: 71030-37-0
Purity:  95.70%
Category:  

Microorganisms

Target:  

Apoptosis

12-HETE, a major metabolic product of arachidonic acid using 12-LOX catalysis, inhibits cell apoptosis in a dose-dependent manner. 12-HETE promotes the activation and nuclear translocation of NF-κB through the integrin-linked kinase (ILK) pathway .12-HETE has both anti-thrombotic and pro-thrombotic effects . 12-HETE is a neuromodulator .
loading...
    loading...
Cat. No.: HY-156876
CAS No.: 2992666-48-3
Purity:  98.12%
Target:  

Cytochrome P450

Research Areas:  

Metabolic Disease

20-HETE inhibitor-2 is an orally active 20-HETE inhibitor. 20-HETE inhibitor-2 can inhibit the activities of CYP4F2 and CYP4A11, thereby suppressing the production of 20-HETE. 20-HETE inhibitor-2 has the effect of improving blood glucose and can be used for the research of various diseases related to 20-HETE such as obesity .
loading...
    loading...
Cat. No.: HY-116196
CAS No.: 128914-47-6
Purity:  98.2%
17-HETE is arachidonic acid metabolite through cytochrome P-450 pathways, which consists of 17R-HETE and 17S-HETE enantiomers. 17-HETE serves as allosteric activator of the cytochrome P450 1B1 and inhibitor of ATPase, induces cardic hypertrophy .
loading...
    loading...
Cat. No.: HY-W472509
CAS No.: 73804-65-6
Synonyms: 11-Hydroxy-5,8,12,14-eicosatetraenoic acid
Target:  

Cytochrome P450

Research Areas:  

Cardiovascular Disease

11-HETE (11-Hydroxy-5,8,12,14-eicosatetraenoic acid) is the activator for cytochrome P450. 11-HETE upregulates the mRNA expressions of CYP1B1, CYP1A1, CYP4A11, CYP4F11, and CYP4F2, induces cell hypertrophy in RL-14 cell, and exhibits potential to be used in cardiovascular diseases .
loading...
    loading...
Cat. No.: HY-116444A
CAS No.: 128914-46-5
16-HETE is arachidonic acid metabolite through subterminal hydroxylation by cytochrome P-450. 16-HETE exhibits vasodilatory and PMN inhibitory effects and serves as biomarker for early stages of non-alcoholic fatty liver disease .
loading...
    loading...
Cat. No.: HY-130219
CAS No.: 133268-58-3
Target:  

Endogenous Metabolite

Research Areas:  

Others

18-HETE (compound 3) is a monooxygenase metabolite of cytochrome P450 (CYP450).18- HETE consists of arachidonic acid bearing a hydroxy substituent at position 18 .
loading...
    loading...
Cat. No.: HY-113516
CAS No.: 942069-11-6
20-HETE Ethanolamide is a metabolite of endocannabinoid Anandamide. 20-HETE Ethanolamide binds to the rat brain cannabinoid CB1 receptor with a Ki of 985 nM .
loading...
    loading...
Cat. No.: HY-156875
CAS No.: 2472030-28-5
Target:  

Cytochrome P450

Research Areas:  

Others

20-HETE inhibitor-1 (comp 83) is a 20-HETE formation inhibitor
loading...
    loading...
Cat. No.: HY-182771
CAS No.: 3119850-82-4
Target:  

Cytochrome P450

Research Areas:  

Metabolic Disease

20-HETE IN-3 is an orally bioavailable 20-HETE synthesis inhibitor. 20-HETE IN-3 can be used in the research of obesity .
loading...
    loading...